<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1158">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146076</url>
  </required_header>
  <id_info>
    <org_study_id>CV risk physical training</org_study_id>
    <nct_id>NCT05146076</nct_id>
  </id_info>
  <brief_title>Home-based Physical Trainings for Reducing Cardiovascular Risk</brief_title>
  <official_title>Home-based Physical Trainings for Reducing Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>István Kósa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Szeged University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective intervention study among metabolic syndrome patients, investigating the effects&#xD;
      of 12 weeks home-based physical training programme with telemonitoring on the anthropometric&#xD;
      parameters, the exercise tolerance and other cardio-metabolic risk factors of the metabolic&#xD;
      syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective intervention study among metabolic syndrome patients, investigating the effects&#xD;
      of 12 weeks home-based physical training programme with telemonitoring on the anthropometric&#xD;
      and laboratory parameters, the exercise tolerance and other cardio-metabolic and other&#xD;
      psycho-social (anxiety, depression, vital exhaustion , sleep disturbances) risk factors of&#xD;
      the metabolic syndrome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>waist circumference (WC) navel</measure>
    <time_frame>12 weeks</time_frame>
    <description>waist circumference measured at navel level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six minutes walk distance (6MWD)</measure>
    <time_frame>12 weeks</time_frame>
    <description>6 minutes walk distance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>body parameter 1</measure>
    <time_frame>12 weeks</time_frame>
    <description>body weight measured in kg-s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body parameter 2</measure>
    <time_frame>12 weeks</time_frame>
    <description>hip circumference measured in cm-s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body parameter 3</measure>
    <time_frame>12 weeks</time_frame>
    <description>BMI calculated from weight (kg-s) and height (m-s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body parameter 4</measure>
    <time_frame>12 weeks</time_frame>
    <description>body composition parameters (fat / muscle / water ratio)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional parameter 1</measure>
    <time_frame>12 weeks</time_frame>
    <description>stress ECG duration time measured in sec</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laboratory parameter 1</measure>
    <time_frame>12 weeks</time_frame>
    <description>glycated haemoglobin (HbA1c) measured in percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laboratory parameter 2</measure>
    <time_frame>12 weeks</time_frame>
    <description>fasting plasma glucose (+PG) measured in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laboratory parameter 3</measure>
    <time_frame>12 weeks</time_frame>
    <description>triglyceride (TG), measured in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laboratory parameter 4</measure>
    <time_frame>12 weeks</time_frame>
    <description>HDL cholesterol, measured in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laboratory parameter 5</measure>
    <time_frame>12 weeks</time_frame>
    <description>total-cholesterol measured in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 1</measure>
    <time_frame>12 weeks</time_frame>
    <description>Anxiety score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 2</measure>
    <time_frame>12 weeks</time_frame>
    <description>Depression score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 3</measure>
    <time_frame>12 weeks</time_frame>
    <description>vital exhaustion score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 4</measure>
    <time_frame>12 weeks</time_frame>
    <description>health locus of control score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 5</measure>
    <time_frame>12 weeks</time_frame>
    <description>perceived stress score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological test result 6</measure>
    <time_frame>12 weeks</time_frame>
    <description>self-control score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>telemedicine supervised group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>physical training supervised by telemonitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>institutional training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>institutional training supervised by physiotherapist</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>home-based physical training</intervention_name>
    <description>home-based physical training minimum 150 min./week with telemonitoring</description>
    <arm_group_label>telemedicine supervised group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>institutional physical training</intervention_name>
    <description>institutional physical training supervised by physiotherapist 2-3 times 60 min./week</description>
    <arm_group_label>institutional training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  voluntary patients aged between 25 and 70 years&#xD;
&#xD;
          -  low level of regular physical activity, less than 30 min./ week&#xD;
&#xD;
          -  basic IT skills&#xD;
&#xD;
          -  3 risk factors present out of the 5 metabolic risk factors from the followings:&#xD;
&#xD;
               1. waist circumference (WC) above 102 cm in men and above 88 cm in women&#xD;
&#xD;
               2. proved type 2 diabetes mellitus (T2DM) or fasting plasma glucose level above 5,6&#xD;
                  mmol/l&#xD;
&#xD;
               3. treated hypertension or spontaneous blood pressure higher or equivalent than 130/&#xD;
                  85 mmHg&#xD;
&#xD;
               4. treated hypertriglyceridaemia or serum triglyceride level above 1,7 mmol/l&#xD;
&#xD;
               5. serum HDL cholesterol level under 1,03 mmol/l in men or 1,3 mmol/l in women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any upcoming planned invasive cardiological intervention&#xD;
&#xD;
          -  uncontrolled hypertension&#xD;
&#xD;
          -  type one diabetes mellitus (T1DM)&#xD;
&#xD;
          -  T2DM which needed more than 1 dose insulin per day&#xD;
&#xD;
          -  chronic heart failure&#xD;
&#xD;
          -  chronic renal failure&#xD;
&#xD;
          -  serious cognitive disfunction&#xD;
&#xD;
          -  lack of cooperation&#xD;
&#xD;
          -  any of known disease or condition that seriously affect the mental and legal capacity&#xD;
&#xD;
          -  any other conditions inhibiting regular physical trainings&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>István Kósa, Med. habil.</last_name>
    <phone>+36703321652</phone>
    <email>kosa.istvan@med.u-szeged.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Éva Máthéné Köteles</last_name>
    <phone>+36 30 272 5994</phone>
    <email>mathene.koteles.eva.szilvia@szte.hu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Szeged, Faculty of Health Sciences and Social Studies, Department of Phisiotherapy</name>
      <address>
        <city>Szeged</city>
        <zip>6726</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mária Barnai, Ph.D.</last_name>
      <phone>+36 62 546 416</phone>
      <email>barnai.maria@szte.hu</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Szeged University</investigator_affiliation>
    <investigator_full_name>István Kósa</investigator_full_name>
    <investigator_title>Head of Department of Medical Prevention</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

